At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 345 enrolled
Drug / intervention
Zabofloxacin +1 moredrug
Likely dose
Zabofloxacin 367mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Trials to Evaluate Efficacy and Safety of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg After Multi-dose Oral Administration in Patients With Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease.
In Brief
A Phase 3 clinical trial evaluating Zabofloxacin and Moxifloxacin for Chronic Obstructive Pulmonary Disease. Completed, enrolled 345 participants across 1 site.
Detailed Summary
The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple dose of Zabofloxacin Tablet 400 mg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
CountriesSouth Korea
CollaboratorsChonbuk National University Hospital, Chosun University Hospital, Bundang CHA Hospital, Chungbuk National University, Kangdong Sacred Heart Hospital, Hanyang University, Asan Medical Center, Gachon University Gil Medical Center, The Catholic University of Korea, Konyang University Hospital, KangWon National University Hospital, Gyeongsang National University Hospital, Kyunghee University Medical Center, Korea University Anam Hospital, DongGuk University, Severance Hospital, Yeungnam University Hospital, Ulsan University Hospital, Ewha Womans University Mokdong Hospital, Inje University, Chonnam National University Hospital, Catholic University of Korea Saint Paul's Hospital, Incheon St.Mary's Hospital, Masan Samsung Hospital, South Korea, Konkuk University Medical Center, Keimyung University Dongsan Medical Center, Wonju Severance Christian Hospital, Hallym University Medical Center, Ajou University, Chungnam National University Hospital
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedAug 2012
Primary CompletionJan 2014
Study CompletionAug 2014
TodayJul 2026
First PostedAug 6, 2012
Enrollment StartAug 1, 2012
Primary CompletionJan 1, 2014
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 13.9 years ago
Interventions
Zabofloxacindrug
Zabofloxacin 367mg tablet P.O. once daily for 5days and then Placebo P.O. once daily for 2days
Moxifloxacindrug
Moxifloxacin 400mg tablet P.O. once daily for 7days